ANTIKOR BIOPHARMA LIMITEDActive
Key figures
ANTIKOR BIOPHARMA LIMITED does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.
Ratios
2024/25Balance sheet structure
Filed accounts2020/21–2024/25
| 2020/21 | 2021/22 | 2022/23 | 2023/24 | 2024/25 | |
|---|---|---|---|---|---|
| Profit for the year | 574,178 | -17,019 | 1,014,042 | 492,758 | 377,249 |
| Cash at bank and in hand | 132,905 | 341,951 | 218,252 | 20,798 | 108,890 |
| Total assets | — | — | — | — | 409,581 |
| Total liabilities | — | — | — | — | 4,460,583 |
| Net assets / total equity | 6,234,432 | 6,644,108 | 8,305,572 | 8,814,566 | 9,199,101 |
| Average number of employees | 12 | 11 | 13 | 12 | 0 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Summary: ANTIKOR BIOPHARMA LIMITED
Company
ANTIKOR BIOPHARMA LIMITED is a private limited company registered with Companies House under company number 04170519. It was incorporated on 1 Mar 2001. Its status is active. The registered office is in London (EC2V). Its nature of business (SIC 2007) is other research and experimental development on natural sciences and engineering (72190).
Accounts
The latest accounts in the database are for 2024/25 (period ending 31 Jul 2025); the company files small company accounts (filleted). Profit for the year was £377,249. Net assets were £9,199,101, up 4.4% on the previous year. Cash at bank and in hand was £108,890. Total assets were £409,581 and total liabilities £4,460,583. The company had an average of 0 employees. Figures are available for 5 financial years (2020/21–2024/25).
Control and charges
2 persons with significant control are registered.
Filing deadlines
The next accounts are due by 15 Oct 2026. The next confirmation statement is due by 26 Jun 2027.